Institute of Hepatobiliary Surgery, Affiliated Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, China.
BMC Cancer. 2010 Aug 17;10:435. doi: 10.1186/1471-2407-10-435.
We investigated the distribution and clinical significance of mobilized endothelial progenitor cells (EPCs) in hepatocellular carcinoma (HCC). We found that many more EPCs were recruited to nonmalignant liver tissue (especially into adjacent non-tumor tissues (AT)) than to tumor vessels. These results suggest that the mechanism underlying the recruitment of EPCs into microvessels in AT merits further investigation
Angiogenic factors were detected in three tissue microarrays comprising normal liver, paired tumor tissue (TT) and AT from 105 patients (who had undergone hepatectomy for HCC) using immunohistochemistry. Also, the number of EPCs (positive for Sca-1, Flk-1 and c-Kit) in the blood and liver of cirrhotic mice were determined by flow cytometry and immunohistochemistry. The distribution of these labeled EPCs in tumor and non-tumor tissues was then studied.
The results from the tissue microarrays showed that the expression levels of VEGF-A, bFGF, TGF-β, MCP-1, TSP-1, MMP-9, TIMP-2, and endostatin were significantly higher in AT than in either normal liver or TT (p < 0.05), but no significant difference was found in the expression levels of COX-2 and NOS-2 between AT and TT. The expression of VEGF-A, bFGF, TGF-β, MCP-1, TSP-1, MMP-9, TIMP-2, endostatin, COX-2, and NOS-2 in normal liver tissue was weaker than that in AT or TT. In cirrhotic mice, the number of circulating endothelial progenitor cells gradually increased, before decreasing again. In this mouse model, increased numbers of EPCs were recruited and homed specifically to the cirrhotic liver.
Both liver cirrhosis and HCC led to increased expression of pro-angiogenic factors, which resulted in the recruitment of EPCs into AT. Also, EPCs were mobilized, recruited and homed to cirrhotic liver. The unique pathology of HCC coupled with liver cirrhosis may, therefore, be associated with the distribution and function of EPCs.
我们研究了动员的内皮祖细胞(EPCs)在肝细胞癌(HCC)中的分布和临床意义。我们发现,与肿瘤血管相比,更多的 EPC 被招募到非恶性肝组织(特别是相邻的非肿瘤组织(AT))中。这些结果表明,EPC 被招募到 AT 微血管中的机制值得进一步研究。
使用免疫组织化学法在三个组织微阵列中检测了来自 105 例(因 HCC 接受肝切除术)患者的正常肝、配对肿瘤组织(TT)和 AT 中的血管生成因子。此外,还通过流式细胞术和免疫组织化学法确定了肝硬化小鼠血液和肝脏中 EPCs(Sca-1、Flk-1 和 c-Kit 阳性)的数量。然后研究了这些标记的 EPC 在肿瘤和非肿瘤组织中的分布。
组织微阵列的结果表明,VEGF-A、bFGF、TGF-β、MCP-1、TSP-1、MMP-9、TIMP-2 和内皮抑素在 AT 中的表达水平明显高于正常肝或 TT(p < 0.05),但 AT 和 TT 之间 COX-2 和 NOS-2 的表达水平没有差异。VEGF-A、bFGF、TGF-β、MCP-1、TSP-1、MMP-9、TIMP-2、内皮抑素、COX-2 和 NOS-2 在正常肝组织中的表达弱于 AT 或 TT。在肝硬化小鼠中,循环内皮祖细胞的数量逐渐增加,然后再次减少。在这种小鼠模型中,增加了 EPC 的募集和归巢到肝硬化肝脏。
肝硬变和 HCC 均导致促血管生成因子表达增加,导致 EPC 募集到 AT。此外,EPC 被动员、募集并归巢到肝硬化肝脏。因此,HCC 独特的病理学与肝硬化可能与 EPC 的分布和功能有关。